跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Montelukast Mevon Chewable Tablets 5mg - HSA Drug Approval Details
Approvals
/
HSA
/
Montelukast Mevon Chewable Tablets 5mg
Approved
THERAPEUTIC
Montelukast Mevon Chewable Tablets 5mg
Pharmathen S.A.
🇸🇬 Health Sciences Authority
Approval Date
Jan 5, 2012
Approval ID
40f8fa2778c21025
Company
Pharmathen S.A.
Type
Therapeutic
Approval Details
Approval Id
40f8fa2778c21025
Drug Name
Montelukast Mevon Chewable Tablets 5mg
Product Name
Montelukast Mevon Chewable Tablets 5mg
Approval Number
SIN14073P
Approval Date
2012-01-05
Registrant
NOVEM PHARMA PRIVATE LIMITED
Licence Holder
NOVEM PHARMA PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, CHEWABLE
Route Of Administration
ORAL
Atc Code
R03DC03
Atc Item Name
montelukast
Pharma Manufacturer Name
NOVEM PHARMA PRIVATE LIMITED
Company Detail Path
/organization/novem-pharma-private-limited
Active Ingredients
Montelukast sodium 5.188mg eq. to Montelukast
5.00mg
MONTELUKAST SODIUM 5.188 MG EQ. TO MONTELUKAST
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 5, 2012
Approval ID
40f8fa2778c21025
Type
Therapeutic
Back to HSA Approvals